Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma

Min Yu(University of Maryland, Baltimore), Zonghai Li(Renji Hospital), Hong Luo, Zeyan Pan(Shanghai Jiao Tong University), Ying Liu(Shanghai Jiao Tong University), Hua Jiang(Shanghai Jiao Tong University), Mingliang Fan(Shanghai Jiao Tong University), Xiuqi Wu(Shanghai Jiao Tong University), Bizhi Shi(Shanghai Jiao Tong University), Shengmeng Di(Shanghai Jiao Tong University)
Molecular Therapy
December 19, 2017
Cited by 184


Related Papers